Effects of Inspiratory Muscle Training in Addition to Pulmonary Rehabilitation in Patients With COPD Exacerbation

Overview

Inspiratory muscle weakness, limited functional exercise capacity and worse quality of life have been shown in patients with exacerbation of chronic obstructive pulmonary disease (COPD). Recommendations from clinical practice guideline state that promoting pulmonary rehabilitation after exacerbation can improve the conditions above. Inspiratory muscle training (IMT) has been proven to enhance inspiratory muscle strength and endurance in patient with stable COPD. However, there is less research on whether IMT in addition to pulmonary rehabilitation after exacerbation can benefit inspiratory muscle function, functional exercise capacity and quality of life in patients with COPD. The purpose of this study is to examine the effects of IMT in addition to pulmonary rehabilitation on respiratory muscle function, functional exercise capacity and quality of life in patients with exacerbation of chronic obstructive pulmonary disease.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Supportive Care
    • Masking: Single (Participant)
  • Study Primary Completion Date: September 16, 2022

Interventions

  • Other: inspiratory muscle training
    • Intensity of inspiratory muscle training will be set at 30% of maximal inspiratory pressure. Subjects in intervention experimental group will perform 15 breaths per set, 6 sets per day on daily basis. The intervention will be last for 8 weeks.
  • Other: pulmonary rehabilitation
    • Pulmonary rehabilitation consists of aerobic exercise training, strength training, and education related to airway clearance and drug utilization. All of subjects will receive 8-week pulmonary rehabilitation.

Arms, Groups and Cohorts

  • Experimental: Inspiratory muscle training combined pulmonary rehabilitation
  • Sham Comparator: Sham inspiratory muscle training combined pulmonary rehabilitation

Clinical Trial Outcome Measures

Primary Measures

  • Diaphragm muscle activation
    • Time Frame: 10 minutes
    • The surface electromyography (EMG) signal was analyzed in the time domain, calculating root mean square (RMS) amplitude with a time constant of 30 mini seconds. A 1.5 seconds window of diaphragm muscle signals at peak pressure during maximal inspiratory pressure test were obtained and calculated as maximal effort. Diaphragm activation were calculated using mean RMS values of each threshold loaded breathing test, and then normalized to maximal effort (%EMGDia).
  • Sternocleidomastoid muscle activation
    • Time Frame: 10 minutes
    • The surface electromyography (EMG) signal was analyzed in the time domain, calculating root mean square (RMS) amplitude with a time constant of 30 mini seconds. A 1.5 seconds window of SCM muscle signals at peak pressure during maximal inspiratory pressure test were obtained and calculated as maximal effort. SCM activation were calculated using mean RMS values of each threshold loaded breathing test, and then normalized to maximal effort (%EMGSCM).

Secondary Measures

  • The mean median frequency of diaphragm and sternocleidomastoid muscle
    • Time Frame: 10 minutes
    • The power spectrum is divided into two equal areas of the frequency value by median frequency to exam muscle fatigue.
  • Functional exercise capacity
    • Time Frame: Considering time of test and recovery, it will be expected to take totally 10 minutes.
    • Six-minute walking test will be performed to evaluate functional exercise capacity.
  • Quality of life evaluation
    • Time Frame: 10 minutes
    • St. George’s Respiratory Questionnaire and COPD assessment test will be used to evaluate quality of life.

Participating in This Clinical Trial

Inclusion Criteria

  • age > 20 years old – diagnosed as exacerbation of COPD – maximal inspiratory pressure (MIP) < 80 cmH2O Exclusion Criteria:

  • any clinical diagnosis that will influence the measurement, including any history of neuromyopathy – angina, acute myocardial infarction in the previous one month – pregnancy – participated in inspiratory muscle training program in the previous three months – any psychiatric or cognitive disorders, for example: Mini-Mental State Examination (MMSE) < 24, that will disturb the communication and cooperation of the study

Gender Eligibility: All

Minimum Age: 20 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • National Taiwan University Hospital
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Li-Ying Wang, PhD, Study Chair, National Taiwan University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.